Home' Australian Pharmacist : Australian Pharmacist October 2015 Contents Australian Pharmacist October 2015 I ©Pharmaceutical Society of Australia Ltd.
records. Despite the introduction of PCEHR,
their uptake by consumers and pharmacies
has, to date, been poor.26 Given the
importance of access to medical records
for consumer safety and the provision of
holistic care, pharmacists and GPs must
work together to resolve this problem.
There is ongoing concern surrounding
the viability of pharmacy services and
their continued remuneration within
the community setting. Participants
recognised that consumers may
not want to pay for services beyond
dispensing, and that government
remuneration was not guaranteed in
the long term. Remuneration models
that would incorporate dispensing
tasks and professional consultation27
Participants sought standards and
guidelines to facilitate implementation,
and additional training to ensure
consumer safety. Rosenthal et al.
questioned whether the need for
further training to provide new
programs reflected a lack of confidence,
and whether ‘pharmacists are the
ultimate barrier to practice change ’.
While this lack of confidence needs to be
overcome, some pharmacists may need
additional support, particularly if they
are not committed to change or don’t
experiment with new services. In this
study, successful introduction of new
services appeared to be associated
with a commitment to change, and top
Australian pharmacy owners and
managers experiment continuously
with new services, ultimately leading to
The need for business
skills development for Australian
pharmacists has also been emphasised.
To facilitate practice change,
organisational culture needs to
embrace innovation, leadership and
staff management, and value team
and communication11 are required to
achieve this. These enablers align with
the ‘whole of pharmacy’ approach.
This includes a commitment from
pharmacy owners and managers to
change practice, e.g. a ‘professionally
active owner’,9 teamwork, and choosing
the right staff members to drive the
service, which may require employing
more staff. Indeed, a ‘whole of pharmacy
approach’ was a key recommendation
to implement a medication compliance
service, including assigning responsibility
to pharmacy staff members.
of trained staff and giving them
ownership of a program was emphasised
by Australian pharmacy owners when
discussing pharmacy management in the
Adequate planning and
seeking advice from other pharmacists
who had successfully implemented new
services were also viewed as strategies,
More than ever, community
pharmacists, particularly owners and
managers, need to be cognisant of these
findings. In order to move forward, the
profession needs to consider and build
on the implementation strategies that
have worked in pharmacies; to focus on
To date, there has been limited success
in sustaining practice change in
Australia, and the main barriers and
enablers to moving forward remain the
same. This begs the question – Are we
at the crossroads or is it Groundhog
Day? While groundhogs are known for
predicting the weather, pharmacy must
pay attention to the winds of change.
Some community pharmacists are
successfully doing this by incorporating
a ‘whole of pharmacy’ approach to
implementing new services. While most
pharmacists did not disagree with the
premise of introducing new or extended
services, they requested guidance and
assistance with implementation.
1. Daniels A. Someone stole the crossroads. Aus Pharmacist.
2. Dolovich L, Gagnon A, McAiney CA, Sparrow L, Burns S. Initial
Pharmacist Experience with the Ontario-Based MedsCheck
Program. Can Pharm J. 2008;141(6):339–45.e1.
3. Marquis J, Schneider MP, Spencer B, Bugnon O, Du Pasquier
S. Exploring the implementation of a medication adherence
programme by community pharmacists: a qualitative study. Int J
Clin Pharm. 2014;36(5):1014–22 .
4. Latif A, Boardman H. Community pharmacists’ attitudes towards
medicines use reviews and factors affecting the numbers
performed. Pharm World Sci. 2008;30(5):536–43.
5. Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced
pharmacy services, barriers and facilitators in Australia’s community
pharmacies: Australia’s National Pharmacy Database Project. Int J
Pharm Pract. 2007;15(3):185–91.
6. Paudyal V, Hansford D, Scott Cunningham IT, Stewart D.
Cross-sectional survey of community pharmacists’ views of the
electronic Minor Ailment Service in Scotland. Int J Pharm Pract.
7. Wells KM, Thornley T, Boyd MJ, Boardman HF. Views and experiences
of community pharmacists and superintendent pharmacists
regarding the New Medicine Service in England prior to
implementation. Res Social Adm Pharm. 2014;10(1):58–71 .
8. Emmerton LM, Smith L, Lemay KS, Krass I, Saini B, Bosnic-Anticevich
SZ et al. Experiences of community pharmacists involved in the
delivery of a specialist asthma service in Australia. BMC Health Serv
9. Hopp TR, Sørensen EW, Herborg H, Roberts AS. Implementation
of cognitive pharmaceutical services (CPS) in professionally active
pharmacies. Int J Pharm Pract. 2005;13(1):21–31.
10. Bradley F, Wagner AC, Elvey R, Noyce PR, Ashcroft DM. Determinants
of the uptake of medicines use reviews (MURs) by community
pharmacies in England: a multi-method study. Health Policy.
11. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice
change in community pharmacy: quantification of facilitators. Ann
Pharmacother. 2008;42(6):861–8 .
12. Doucette WR, Nevins JC, Gaither C, Kreling DH, Mott DA, Pedersen
CA et al. Organizational factors influencing pharmacy practice
change. Res Social Adm Pharm. 2012;8(4):274–84.
13. Scahill SL, Carswell P, Harrison J. An organizational culture gap
analysis in 6 New Zealand community pharmacies. Res Social Adm
14. Scahill S, Harrison J, Carswell P. Describing the organisational culture
of a selection of community pharmacies using a tool borrowed
from social science. Pharm World Sci. 2010;32(1):73–80 .
15. McMillan SS, Kelly F, Sav A, Kendall E, King MA, Whitty JA et al.
Consumers and Carers Versus Pharmacy Staff: Do Their Priorities
for Australian Pharmacy Services Align? Patient. 2014. doi:10.1007/
16. McMillan SS, Sav A, Kelly F, King M.A, Whitty JA, Wheeler AJ. Is the
pharmacy profession innovative enough?: meeting the needs of
Australian residents with chronic conditions and their carers using
the nominal group technique. BMC Health Serv Res. 2014;14(1):476.
17. McMillan SS, Sav A, Kelly F, King MA, Whitty JA, Wheeler AJ. How to
attract them and keep them: the pharmacy attributes that matter
to Australian residents with chronic conditions. Int J Pharm Pract.
18. McMillan SS, Kelly F, Sav A, Kendall E, King MA, Whitty JA et al. Using
the Nominal Group Technique: How to analyse across multiple
groups. Health Serv Outcomes Res Method. 2014;14:92–108.
19. Dey RM, de Vries MJW, Bosnic-Anticevich S. Collaboration in
chronic care: unpacking the relationship of pharmacists and
general medical practitioners in primary care. Int J Pharm Pract.
20. Rieck AM. Exploring the nature of power distance on general
practitioner and community pharmacist relations in a chronic
disease management context. J Interprof Care. 2014;28(5):440–6 .
21. Van C, Costa D, Mitchell B, Abbott P, Krass I. Development and
validation of a measure and a model of general practitioner
attitudes toward collaboration with pharmacists. Res Social Adm
22. Francis C, Cannings J, Jessop R, Thew S, Li J, Benrimoj C. Professional
Collaboration. Canberra, ACT: Australian Government Department
of Health and Ageing, The Pharmacy Guild of Australia, 2014.
23. Rosenthal M, Austin Z, Tsuyuki RT. Are Pharmacists the
Ultimate Barrier to Pharmacy Practice Change? Can Pharm J.
24. Scahill SL. Community pharmacy does not appear as part of the
collaboration discourse within New Zealand primary care. J Prim
Health Care. 2011;3(3):244–7 .
25. The Pharmacy Guild of Australia. PSA and Pharmacy Guild in
QLD immunisation trial. 2013. http://www.guild.org.au/news-
trial. Accessed 15 Jul 2014.
26. National E-Health Transition Authority. NEHTA Scorecard, Aug
27. Pharmaceutical Society of Australia. Better health outcomes
through improved primary care: Optimising pharmacy ’s
contribution. ACT: PSA, 2014.
28. Woods P, Gapp R, King MA. A grounded exploration of the
dimensions of managerial capability: A preliminary study of top
Australian pharmacist owner-managers. Res Social Adm Pharm.
29. Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Building capacity
to implement cognitive pharmaceutical services: Quantifying
the needs of community pharmacies. Res Social Adm Pharm.
30. Feyer AM, Benrimoj SI, Schulman C, Jessop R, Pyper D, Sabet B et al.
National trial to test strategies to improve medication compliance
in a community pharmacy setting. Canberra, ACT: Australian
Government Department of Health and Ageing, The Pharmacy
Guild of Australia, 2010.
31. Mah E, Rosenthal M, Tsuyuki RT. Study of Understanding Pharmacists’
Perspectives on Remuneration and Transition toward Chronic Disease
Management (SUPPORT-CDM): Results of an Alberta-Wide Survey of
Community Pharmacists. Can Pharm J. 2009;142(3):136–43.e1.
32. McMillan SS, Kelly F, Sav A, King MA, Whitty JA, Wheeler AJ.
Australian community pharmacy services: a survey of what people
with chronic conditions and their carers use versus what they
consider important. BMJ Open. 2014;4(12):e006587
Links Archive Australian Pharmacist September 2015 Australian Pharmacist November 2015 Navigation Previous Page Next Page